The largest database of trusted experimental protocols

Cd3 cd28 activator beads

Manufactured by Thermo Fisher Scientific
Sourced in United Kingdom

CD3/CD28 activator beads are a specialized lab equipment product designed for T-cell activation. They are magnetic beads coated with antibodies against the CD3 and CD28 receptors on T-cells, which are essential for T-cell activation and proliferation.

Automatically generated - may contain errors

6 protocols using cd3 cd28 activator beads

1

Glucose-Mediated CD8+ T Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were obtained from healthy donors as described elsewhere (20 (link)). Primary human CD8+ T cells were negatively isolated from PBMCs using Human CD8+ T Cell isolation Kits (Miltenyi Biotec). Human CD8+ T cells were stimulated with CD3/CD28 activator beads (Thermo Fisher Scientific) and cultured in DMEM medium (Thermo Fisher Scientific) containing normal (5.6 mM) or high glucose (25 mM) for up to three days if not otherwise mentioned. Levels of glucose in medium was examined every day using “Contour Next Sensoren” test strips (SMS Medipool) and consumed glucose was compensated accordingly. If CTLs were cultured longer than three days, human recombinant IL-2 (Miltenyi Biotec) was added to the medium every two days from day 2 on (100 U/ml). All cells were cultured at 37°C with 5% CO2. Human pancreatic beta cell line 1.4E7 was purchased from Merck and cultured in RPMI-1640 medium (Thermo Fisher Scientific) supplemented with 2 mM glutamine, 1% Penicillin-Streptomycin plus 10% FCS (ThermoFisher Scientific).
+ Open protocol
+ Expand
2

Senescent Cholangiocyte-CD4+ Cell Co-Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cholangiocytes were seeded at 1 × 105 cells per well in a 24 well companion plate (Corning) in 80 μL phenol red‐free H69 media and cultured overnight. Senescence was induced in cholangiocytes as previously described before addition of CD4+ cells. 0.4 μm inserts (Corning) were placed above with freshly isolated CD4+ cells at a density of 1 × 106 cells in 500 μL Iscove's Modified Dulbecco's Medium (Sigma, Poole, UK) supplemented with 10% FBS, 2 mmol/L L‐glutamine, 100 IU penicillin and 100 μg/mL streptomycin as shown in Figure 1A. CD4+ cells were activated using CD3/CD28 activator beads (Thermo Fisher, Paisley, UK) at a ratio of 1 bead to 2 cells. Co‐cultures were left in culture for 72 hours before analysis.
+ Open protocol
+ Expand
3

Diabetes Immune Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected from patients with diabetes type 1 and 2 (using the current diagnostic criteria from the American Diabetes Association-ADA) and healthy control subjects (all with normal glycated haemoglobin level (HbA1c < 5,7%) at the day of the blood sample collection). Both patients and healthy controls were recruited in the Department of Internal Medicine II in the Saarland University Medical Center, Homburg, Saarland, Germany. Written informed consent was obtained from all subjects before blood sampling, strictly following the procedure described in the ethical approval of the ethic committee of the medical association of Saarland (Ethic Vote Nr: Ha 84/19). PBMCs were obtained from the blood samples and were stimulated with CD3/CD28 activator beads (Thermo Fisher Scientific) and cultured in DMEM containing normal (5.6 mM) or high glucose (25 mM) for three days, supplemented with recombinant IL-2 (100 U/ml, Miltenyi).
+ Open protocol
+ Expand
4

Culturing CD8+ T Cells under Glucose Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Raji cells were cultured in RPMI-1640 medium (ThermoFisher Scientific) containing 10% FCS and 1% Penicillin-Streptomycin. Peripheral blood mononuclear cells (PBMCs) were obtained from healthy donors as described before (24 (link)). Primary human CD8+ T cells were negatively isolated from PBMCs using Human CD8+ T Cell isolation Kits (Miltenyi Biotec) according to the manufacturer’s instruction. Human CD8+ T cells were stimulated with CD3/CD28 activator beads (ThermoFisher Scientific) and cultured in DMEM containing normal (5.6 mM, NG) or high glucose (25 mM, HG) (ThermoFisher Scientific) for 3 days if not otherwise mentioned. Since day 2, additional glucose was added into the medium every two days to compensate the consumed glucose along with recombinant human IL-2 (50 ng/ml, ThermoFisher Scientific). All cells were cultured at 37°C with 5% CO2. EG7 mouse lymphoma cell line was stably transfected with 4 µg of pCasper-pMax plasmid (25 (link)) using SF Cell Line 4D-NucleofectorTM X Kit (Lonza). 48h after transfection, cells were treated with 0.4 mg/ml G418 and 4 µg/ml puromycin in RPMI-1640 (ThermoFisher Scientific) with 10% FCS. Monoclonally expanded EG7-pCasper cells were cultured in selection medium, supplemented with 1% Penicillin/Streptomycin. Flow cytometry analysis revealed 98% of EG7-pCasper cells were fluorescent.
+ Open protocol
+ Expand
5

Expanded AAV-edited Cell Sorting

Check if the same lab product or an alternative is used in the 5 most similar protocols
AAV edited cells were expanded for seven days in culture then rested 24 hours without cytokine. Cells were then bulk sorted based on editing outcome, using a FACS Aria I. Cells were gated on size and singlets, then sorted on BFP/GFP positivity. After sorting cells were expanded with CD3/CD28 Activator Beads (Gibco) at 1 bead to 50 cells (ratios of beads to cells higher than 1:25 caused severe activation induced cell death).
+ Open protocol
+ Expand
6

Comprehensive Immunophenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-human CD4FITC (eBioscience 11-0049)), CD3PerCpCy5.5 (eBioscience 45-0037), CD8PE (eBioscience 12-0088), CD45ROFITC, CD45RAPE, TNFα eFlour450 (eBioscience 48-7349), IFNγAPC (eBioscience 17-7319), TbetPE (eBioscences 12-5825-80), eomesPE-eFlour610 (eBioscience 61-4877) and appropriate isotype control antibodies as well as human Fc Receptor binding inhibitor (eBioscience 14-9161), Protein transport inhibitor (Brefeldin A and Monensin (eBioscence 00-4980)), PMA and Ionomycin (T cell stimulation cocktail (eBioscience 00-4970 )), Intracellular fixation and permeabilization kit (eBioscience 88-8824) FOXP3/transcription factor staining kit (eBioscience 00-5523). FACS lysing buffer was obtained from BD Biosciences (BD 349202). CD279 PECy7 (BioLegend 329917), CD8AF700 (BioLegend 301028), CCR7APC (BioLegend 353214), GranzymeBAlexaFlour647 (BioLegend 515405), CD107eFlour450 (eBioscience 48-1079) and appropriate isotype controls. CD3/CD28 activator beads (Gibco 11131D), EBV peptides; HLA A2.1 (GLCTLVAML), HLA A2.2 (CLGGLLTMV), HLA A2.3 (LLDFVRFMGV), HLA B7.1 (RPPIFIRRL), HLA B7.2 (VPAPAGPIV), HLA B8.1 (RAKFKQLL), HLA B8.2 (QAKWRLQTL), HLA B8.3 (FLRGRAYGL). Peptides were obtained from Invitrogen.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!